Company
About us
Company introduction
Insight into Clinical Value and Market Potential
WhalesMedi Co., Ltd. is strategically addressing the unmet needs in Korea’s infection treatment market, guided by our insight into both clinical value and market potential. We will continue to grow hand in hand with the medical field.
- ①Strategic licensing-in
- ②Evidence-based hospital marketing & sales
- ③Strengthening global export strategies
WhalesMedi leverages its expertise in pharmaceutical distribution and marketing with a strategic focus on strategic licensing-in, evidence-based hospital marketing & sales, and strengthening global export strategies.
Beyond simple distribution, we selectively introduce products that combine clinical necessity with market potential, delivering them in ways that meet the needs of healthcare institutions.
By expanding our portfolio with a focus on severe infection therapies and enhancing our hospital-tailored marketing and academic support capabilities, we are building strong, trust-based partnerships with medical institutions across Korea.
Looking ahead, WhalesMedi will continue to grow as a responsive distribution platform company by securing strategic product in-licensing, expanding supply, reinforcing hospital sales capabilities, and establishing export channels. Through these efforts, WhalesMedi aims to become the most trusted commercialization partner in the field of infectious disease treatment.
Greeting
CEO’s greeting
Like a whale swimming through the vast ocean,
we look far ahead and move with depth.
The whale in the WhalesMedi logo is more than just an image.
精益求精 — ‘the pursuit of excellence beyond the good.’
We are committed to carefully selecting the products most needed in clinical practice and delivering them in meaningful ways, striving to move beyond simple distribution to become a true value connector in healthcare.
Currently, our focus is on a portfolio of antibiotics for severe infections, dedicated to offering trusted therapeutic options in life-threatening situations.
With thorough preparation, steady navigation, and a far-reaching vision, WhalesMedi will continue to be the most meaningful partner at the most critical moments for both healthcare providers and patients.
Sincerely,
Duk-Jung Yoon, CEO, WhalesMedi Co., Ltd.
Mission
Our mission
- 01A company that develops innovative new drugs
- 02A company that is trusted and respected by customers and employees
- 03A company that walks with the socially disadvantaged
FAQ
Frequently asked questions
What is WhalesMedi?
WhalesMedi Co., Ltd. is a Korean pharmaceutical distribution and marketing company addressing unmet needs in the infection treatment market, focusing on antibiotics for severe infections, strategic licensing-in and global export.
What are WhalesMedi’s strategic priorities?
Strategic licensing-in, Evidence-based hospital marketing & sales, Strengthening global export strategies.
Which product areas does WhalesMedi cover?
Pharmaceuticals, medical devices, cosmetics and health functional foods, through domestic distribution in Korea and export/import trade.
Where is WhalesMedi located and how can I contact you?
7F, 62, Hancheon-ro, Dongdaemun-gu, Seoul, Republic of Korea (Jangan-dong, Hwaseong Building). Phone +82-2-2135-3797, e-mail master@whalesmedi.com.